Jiangsu, China

Tao Chen

This inventor holds 9 USPTO granted patents and 12 published patent applications and 4 EPO patents. Top assignees: Jiangsu Jiuhui Technology Co., Ltd., Qyuns Therapeutics Co., Ltd., Qyuns Therapeutics Co., Ltd.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tao Chen. Retrieved from https://idiyas.com/inventor/tao-chen-zvjymq2l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Taizhou, CN (2023)
  • Jiangsu, CN (2018 - 2024)

Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Tao Chen

Introduction

Tao Chen is a prominent inventor based in Jiangsu, China, known for his significant contributions to the field of biotechnology. With a total of seven patents to his name, he has made remarkable advancements in the development of monoclonal antibodies for therapeutic applications.

Latest Patents

Among his latest patents is the invention of an anti-human thymic stromal lymphopoietin (TSLP) monoclonal antibody. This antibody exhibits high affinity for human TSLP and possesses neutralizing activity, making it a potential treatment for TSLP-mediated diseases. Another notable patent is the anti-human interleukin-33 monoclonal antibody, which also demonstrates high affinity and neutralizing activity, aimed at preventing or treating diseases mediated by human interleukin-33.

Career Highlights

Tao Chen has worked with several companies, including Qyuns Therapeutics Co., Ltd. and Jiangsu Jiuhui Technology Co., Ltd. His work in these organizations has been instrumental in advancing research and development in the field of monoclonal antibodies.

Collaborations

Tao Chen has collaborated with notable colleagues such as Jiwan Qiu and Wei Chen, contributing to various projects that enhance the understanding and application of monoclonal antibodies in medicine.

Conclusion

Tao Chen's innovative work in the field of biotechnology, particularly in monoclonal antibodies, showcases his dedication to advancing medical treatments. His contributions are paving the way for new therapeutic options in the fight against various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…